NCT04609033View on ClinicalTrials.gov

Implications of Different Analgesic Models on Inflammatory Markers After Laparoscopic Cholecystectomy

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 24, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

March 30, 2021

Conditions
Perioperative Pain
Interventions
DRUG

Bupivacaine

instillation of local anaesthetic in the abdominal cavity at the end of the procedure

DRUG

isotonic saline

instillation of local anaesthetic in the abdominal cavity at the end of the procedure

DRUG

Bupivacaine + morphine

instillation of local anaesthetic + morphine sulfate in the abdominal cavity at the end of the procedure

DRUG

Bupivacaine + morphine + ketamine

instillation of local anaesthetic + morphine sulfate + ketamine in the abdominal cavity at the end of the procedure

Trial Locations (1)

71515

Assiut University Hospitals, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04609033 - Implications of Different Analgesic Models on Inflammatory Markers After Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter